Glutathione Metabolism Contributes to the Induction of Trained Immunity.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
21 04 2021
Historique:
received: 06 04 2021
revised: 14 04 2021
accepted: 19 04 2021
entrez: 30 4 2021
pubmed: 1 5 2021
medline: 26 10 2021
Statut: epublish

Résumé

The innate immune system displays heterologous memory characteristics, which are characterized by stronger responses to a secondary challenge. This phenomenon termed trained immunity relies on epigenetic and metabolic rewiring of innate immune cells. As reactive oxygen species (ROS) production has been associated with the trained immunity phenotype, we hypothesized that the increased ROS levels and the main intracellular redox molecule glutathione play a role in the induction of trained immunity. Here we show that pharmacological inhibition of ROS in an in vitro model of trained immunity did not influence cell responsiveness; the modulation of glutathione levels reduced pro-inflammatory cytokine production in human monocytes. Single nucleotide polymorphisms (SNPs) in genes involved in glutathione metabolism were found to be associated with changes in pro-inflammatory cytokine production capacity upon trained immunity. Also, plasma glutathione concentrations were positively associated with ex vivo IL-1β production, a biomarker of trained immunity, produced by monocytes of BCG-vaccinated individuals. In conclusion, glutathione metabolism is involved in the induction of trained immunity, and future studies are warranted to explore its functional consequences in human diseases.

Identifiants

pubmed: 33919212
pii: cells10050971
doi: 10.3390/cells10050971
pmc: PMC8143087
pii:
doi:

Substances chimiques

Cytokines 0
Reactive Oxygen Species 0
Glutathione GAN16C9B8O

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Netherlands Organization for Scientific Research
ID : 09150161910024
Organisme : FP7 Ideas: European Research Council
ID : 833247

Références

Cell Host Microbe. 2012 Aug 16;12(2):223-32
pubmed: 22901542
Nat Genet. 2016 Oct;48(10):1279-83
pubmed: 27548312
Cell Rep. 2020 Nov 17;33(7):108387
pubmed: 33207187
Free Radic Biol Med. 2017 Nov;112:36-48
pubmed: 28705657
STAR Protoc. 2021 Feb 24;2(1):100365
pubmed: 33718890
Cell Metab. 2016 Dec 13;24(6):807-819
pubmed: 27866838
J Clin Invest. 2020 Oct 1;130(10):5591-5602
pubmed: 32692728
PLoS One. 2015 Mar 20;10(3):e0120254
pubmed: 25793262
Anal Chem. 2011 Sep 15;83(18):7074-80
pubmed: 21830798
Cell Rep. 2020 Apr 21;31(3):107548
pubmed: 32320649
Trends Immunol. 2013 Sep;34(9):431-9
pubmed: 23680130
Bioinformatics. 2012 May 15;28(10):1353-8
pubmed: 22492648
Cell. 2016 Nov 17;167(5):1354-1368.e14
pubmed: 27863248
Arterioscler Thromb Vasc Biol. 2014 Aug;34(8):1731-8
pubmed: 24903093
Bioinformatics. 2012 Jun 15;28(12):1598-603
pubmed: 22500001
Cell. 2020 Oct 29;183(3):771-785.e12
pubmed: 33125892
Cardiovasc Res. 2020 Feb 1;116(2):317-328
pubmed: 31119285
Nat Rev Immunol. 2020 Jun;20(6):375-388
pubmed: 32132681
Science. 2014 Sep 26;345(6204):1250684
pubmed: 25258083
Anal Chim Acta. 2017 Aug 8;980:1-24
pubmed: 28622799
BMC Res Notes. 2014 Dec 11;7:901
pubmed: 25495213
Front Immunol. 2019 Jan 22;9:3155
pubmed: 30723479
Cell. 2018 Jan 11;172(1-2):176-190.e19
pubmed: 29328912
Circ Res. 2018 Mar 16;122(6):877-902
pubmed: 29700084
Clin Vaccine Immunol. 2016 Dec 5;23(12):926-933
pubmed: 27733422

Auteurs

Anaisa V Ferreira (AV)

Department of Internal Medicine and Radboud Center for Infectious Diseases (RCI), Radboud University Nijmegen Medical Center, 6500 HB Nijmegen, The Netherlands.
Instituto de Ciências Biomédicas Abel Salazar (ICBAS), Universidade do Porto, 4050-313 Porto, Portugal.

Valerie A C M Koeken (VACM)

Department of Internal Medicine and Radboud Center for Infectious Diseases (RCI), Radboud University Nijmegen Medical Center, 6500 HB Nijmegen, The Netherlands.
TWINCORE, a joint venture between the Helmholtz-Centre for Infection Research (HZI) and the Hannover Medical School (MHH), 30625 Hannover, Germany.
Centre for Individualised Infection Medicine (CiiM), Department of Computational Biology for Individualised Infection Medicine, a joint venture between the Helmholtz-Centre for Infection Research (HZI) and the Hannover Medical School (MHH), 30625 Hannover, Germany.

Vasiliki Matzaraki (V)

Department of Internal Medicine and Radboud Center for Infectious Diseases (RCI), Radboud University Nijmegen Medical Center, 6500 HB Nijmegen, The Netherlands.

Sarantos Kostidis (S)

Center for Proteomics and Metabolomics, Leiden University Medical Center (LUMC), 2333 ZA Leiden, The Netherlands.

Juan Carlos Alarcon-Barrera (JC)

Center for Proteomics and Metabolomics, Leiden University Medical Center (LUMC), 2333 ZA Leiden, The Netherlands.

L Charlotte J de Bree (LCJ)

Department of Internal Medicine and Radboud Center for Infectious Diseases (RCI), Radboud University Nijmegen Medical Center, 6500 HB Nijmegen, The Netherlands.

Simone J C F M Moorlag (SJCFM)

Department of Internal Medicine and Radboud Center for Infectious Diseases (RCI), Radboud University Nijmegen Medical Center, 6500 HB Nijmegen, The Netherlands.

Vera P Mourits (VP)

Department of Internal Medicine and Radboud Center for Infectious Diseases (RCI), Radboud University Nijmegen Medical Center, 6500 HB Nijmegen, The Netherlands.

Boris Novakovic (B)

Epigenetics Research, Murdoch Children's Research Institute, Parkville, VIC 3052, Australia.
Department of Paediatrics, University of Melbourne, Melbourne, VIC 3052, Australia.

Martin A Giera (MA)

Center for Proteomics and Metabolomics, Leiden University Medical Center (LUMC), 2333 ZA Leiden, The Netherlands.

Mihai G Netea (MG)

Department of Internal Medicine and Radboud Center for Infectious Diseases (RCI), Radboud University Nijmegen Medical Center, 6500 HB Nijmegen, The Netherlands.
Department for Genomics & Immunoregulation, Life and Medical Sciences Institute (LIMES), University of Bonn, 53115 Bonn, Germany.

Jorge Domínguez-Andrés (J)

Department of Internal Medicine and Radboud Center for Infectious Diseases (RCI), Radboud University Nijmegen Medical Center, 6500 HB Nijmegen, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH